NCH2.DENCH2.DEXETRA
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank20
3Y CAGR-52.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-52.5%/yr
Annual compound
Percentile
P20
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 5.28% |
| 2024 | 85.57% |
| 2023 | 21.02% |
| 2022 | 49.17% |
| 2021 | 58.66% |
| 2020 | 0.00% |